Take a trial of UK to unlock this pageFind out more

Momentum
Relative Strength (%)
1m
3m
1yr
Volume Change (%)
10d v 3m
Price vs... (%)
52w High
50d MA
200d MA
vs.
market
vs.
industry
Growth & Value
Margin of Safety (beta)
Screens Passed 1
Balance Sheet · Income Statement · Cashflow Financial Summary
Year End 31st Dec 2009 2010 2011 2012 2013 2014 2015E 2016E CAGR / Avg
Revenue £m
Operating Profit £m
Net Profit £m
EPS Reported p
EPS Normalised p
EPS Growth %
PE Ratio x
PEG x
Profitability
Operating Margin %
ROA %
ROCE %
ROE %
Cashflow
Op. Cashflow ps p
Capex ps p
Free Cashflow ps p
Last ex-div: 4th Jun, paid: 2nd Jul more... Dividends
Dividend ps p
Dividend Growth %
Dividend Yield %
Dividend Cover x
Balance Sheet
Cash etc £m
Working Capital £m
Net Fixed Assets £m
Net Debt £m
Book Value £m
Average Shares m
Book Value ps p +5.8%

FINANCIAL BRIEF: For the fiscal year ended 31 December 2014, Bioquell plc revenues increased 1% to L45.3M. Net loss totaled L1M vs. income of L3.1M. Revenues reflect TRaC segment increase of 7% to L18M, United Kingdom segment increase of 9% to L22M. Net loss reflects BIO segment loss totaling L2.9M vs. income of L1M, Unallocated Head Office Costs segment loss increase of 17% to L1.8M. Dividend per share remained flat at L0.03. more »

Health Trend
Bankruptcy Risk
  Earnings Manipulation Risk
Magic Formula Score
D+
D+
Other Ratios
Leverage (ttm) Total Ex Intang
Gross Gearing %
Net Gearing %
Cash / Assets %
vs.
market
vs.
industry
Recent History
Latest interim period (ended 31st Dec '14) vs. prior year
Sales Growth %
EPS Growth %
3yr Compound Annual Growth Rate
Sales Growth %
EPS Growth %
DPS Growth %

Broker Forecasts
31st Dec 2015
31st Dec 2016

Price Target: 1.47
(+4.61% above Price)
Net Profit EPS DPS Net Profit EPS DPS
Est. Long Term Growth Rate: n/a (£) (p) (p) (£) (p) (p)
Consensus Estimate
1m Change
3m Change
1 brokers Broker Consensus Trend
Broker Recommendations for Bioquell
Recommendation:Strong SellSellHoldBuyStrong Buy
No. of Analysts: 0 0 0 0 1

Named Brokers and Analysts
Investec Bank (UK) Plc Nicholas Keher , N+1 Singer ,

Profile Summary

Bioquell Plc is a United Kingdom-based company engaged in the design, manufacture and supply of bio-decontamination and containment equipment, related products and services to the pharmaceutical, healthcare, food and defense industries, and testing services to the aerospace, telecoms, defense and other industries. The Company operates in two divisions: Bio-decontamination (BIO) and Testing, Regulatory and Compliance (TRaC). BIO division offers specialist hydrogen peroxide vapor bio-decontamination equipment and services for the life sciences, healthcare and defense sectors, and chemical, biological, radiological and nuclear (CBRN) filtration systems for the defense sector. The BIO division also provides after sales customer service and support for laboratory filtration and containment equipment under the name Microflow and Astec. The TRaC division offers testing, regulatory and compliance services.

Directors: Nicholas Adams (CEO) , Michael Roller (FID) 49, Georgina Pope (SEC) , Nigel Keen (NEC) , Tony Bourne (NID) 60, Ian Carruthers (NID) , Simon Constantine (NID) 55, Christopher Mills (NID) 62,

No. of Employees: 444 No. of Shareholders: n/a


Last Annual December 31st, 2014
Last Interim December 31st, 2014
Incorporated June 2, 1925
Shares in Issue 42,535,363
Free Float 16.3m (38.3%)
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index FTSE Fledgling , FTSE Fledgling Ex Investment Trusts ,
Exchange London Stock Exchange (Full)
Eligible for an ISA? a SIPP?

BQE Share Price Performance BQEQuote
140p
-0.5  -0.4%
Traded 8:50am · Minimum 15 min delayed · NMS: 1.50k


Use of our data service is subject to express Terms of Service. Please see our full site disclaimer for more details. In particular, it is very important to do your own research (DYOR) and seek professional advice before making any investment based on your own personal circumstances. Please note that the information, data and analysis contained within this stock report: (a) include the proprietary information of Stockopedia's third party licensors and Stockopedia; (b) should not be copied or redistributed except as specifically authorised; and (c) are not warranted to be complete, accurate or timely. You should independently research and verify any information that you find in this report. Stockopedia will not be liable in respect of any loss, trading or otherwise, that you may suffer arising out of such information or any reliance you may place upon it. Past performance is no guarantee of future results. The value and income derived from investments may go down as well as up. © Stockopedia 2015.


Should you buy BQE

Access BQE Analytics Now!

FREE TRIAL or TAKE THE TOUR
Let’s get you setup so you get the most out of our service
Done, Let's add some stocks
Brilliant - You've created a folio! Now let's add some stocks to it.

  • Apple (AAPL)

  • Shell (RDSA)

  • Twitter (TWTR)

  • Volkswagon AG (VOK)

  • McDonalds (MCD)

  • Vodafone (VOD)

  • Barratt Homes (BDEV)

  • Microsoft (MSFT)

  • Tesco (TSCO)
Save and show me my analysis
Foliobuilder